How to Build a Payer-Tier Appeal Strategy Using the New CMS-0057-F Data
Earlier this month we published our 2026 Payer Prior Authorization Report Card, the first comprehensive look at what the public CMS-0057-F disclosures actually reveal about how Medicare Advantage and Medicaid MCO plans handle prior authorization. If you have not read it yet, start there. The benchmarks, payer-by-payer scorecard, and overturn rate data set the stage for everything that follows.
The data is now out. UnitedHealthcare denies 12.8% of MA prior authorization requests. Centene denies 12.3% and reverses 95.5% of those denials when providers appeal. The industry average appeal overturn rate is 80.7%, but only 11.5% of denials are ever appealed.
If you read the report card, you already know what is on the table. The harder question is the one that comes next. How do you turn that data into a workflow your billing team can run on Monday morning?
This is the operational follow-up. Here is how to build a payer-tier appeal strategy that uses the new public benchmarks to recover revenue your practice is currently leaving behind.
Step 1: Layer Your Own Data on Top of the Benchmarks
Before you can tier payers, you need a clear view of your own denial volume. Most practice management systems can produce a denial report by payer for the prior 12 months. Pull that data and capture three numbers for each payer:
- Total prior authorization requests submitted
- Denials received (with denial rate calculated)
- Appeals filed and outcomes (with appeal win rate calculated)
Compare your own denial rate by payer to the published CMS-0057-F benchmark. Anywhere your rate exceeds the public number, you have either a process gap on your side or a pattern worth documenting on the payer side. Either way, it is actionable.
Step 2: Group Your Payers Into Three Tiers
Once you have the data, group your payers into three tiers based on a single principle: where is appeal effort most likely to convert into recovered revenue?
Tier 1: Appeal Everything
These are payers with both high denial rates and high overturn rates. Centene is the canonical example. A 12.3% denial rate combined with a 95.5% overturn rate means almost every denial that comes back from Centene is going to reverse if you appeal it. The math is unambiguous. For Tier 1 payers, build a default-to-appeal workflow. Standing protocols. Pre-built templates. Automatic routing to your appeals team within 48 hours of denial receipt. Anything less is leaving money on the table.
Tier 2: Appeal Strategically
These are payers with moderate denial rates and moderate-to-high overturn rates. Many of the major MA plans fall here. The math still favors appealing, but you have less margin for inefficiency. Triage matters. For Tier 2 payers, focus appeal effort on higher-dollar claims first, specialties with documented payer denial patterns (oncology, behavioral health, post-acute care), denials that cite vague reasons that the new CMS-0057-F specificity requirements would not allow, and cases where clinical documentation supports a clear appeal narrative.
Tier 3: Triage and Track
These are payers with low denial rates relative to the benchmark. Elevance and Humana fall here in the current MA data. The volume of appealable denials is lower, so the workflow shifts from systematic appeal to selective appeal. For Tier 3 payers, focus appeal effort on high-dollar claims, cases with clear clinical justification, and patterns that may indicate a payer-side issue worth escalating. Track everything anyway. If a Tier 3 payer’s denial rate starts to climb, you want the data to spot the shift early.
Step 3: Use the New Specificity Requirements as an Appeal Lever
CMS-0057-F now requires payers to provide specific reasons for prior authorization denials. That is a workflow change for them, and it is an appeal opportunity for you.
Train your appeals team to flag any denial that arrives with a vague reason like ‘not medically necessary’ without supporting context. Those denials do not meet the new standard. Citing the rule directly in your appeal letter changes how the peer-to-peer reviewer reads it.
Pre-build appeal letter language that references CMS-0057-F’s specificity requirements and reuse it across denials that fit the pattern. The compounding time savings are significant once it is running.
Step 4: Build the Reporting Loop
A tier strategy is only as good as your ability to track whether it is working. Build a monthly reporting view that captures five metrics:
- Denial rate by payer this month versus trailing 12 months
- Appeal rate (denials appealed divided by denials received)
- Appeal win rate by payer
- Average days from denial to appeal filing
- Average days from appeal filing to resolution
These five numbers tell you whether your tier strategy is converting. If your appeal win rate against Centene drops below the published 95.5% benchmark, that is a signal worth investigating. If your appeal filing time slips past the 48-hour standard for Tier 1 payers, your team needs more capacity or better tooling.
Where Clearinghouse Infrastructure Comes In
A clean clearinghouse layer reduces the volume of denials you have to appeal in the first place. Real-time eligibility verification, complete clinical documentation submission, and accurate ERA processing all reduce the noise that turns into preventable denials.
Harris Secure Connect has spent 26 years helping practices build the foundation that makes denial management actually work. If your team is ready to operationalize the new CMS-0057-F data and you want to talk through how clearinghouse infrastructure supports a tiered appeal strategy, we are happy to walk through it with you.